These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 15123725)
1. Hepatic nuclear factor 3 and nuclear factor 1 regulate 5-aminolevulinate synthase gene expression and are involved in insulin repression. Scassa ME; Guberman AS; Ceruti JM; Cánepa ET J Biol Chem; 2004 Jul; 279(27):28082-92. PubMed ID: 15123725 [TBL] [Abstract][Full Text] [Related]
2. Identification of transacting factors responsible for the tissue-specific expression of human glucose transporter type 2 isoform gene. Cooperative role of hepatocyte nuclear factors 1alpha and 3beta. Cha JY; Kim H; Kim KS; Hur MW; Ahn Y J Biol Chem; 2000 Jun; 275(24):18358-65. PubMed ID: 10748140 [TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of AP-1 complex on 5-aminolevulinate synthase gene expression through sequestration of cAMP-response element protein (CRE)-binding protein (CBP) coactivator. Guberman AS; Scassa ME; Giono LE; Varone CL; Cánepa ET J Biol Chem; 2003 Jan; 278(4):2317-26. PubMed ID: 12433930 [TBL] [Abstract][Full Text] [Related]
4. The promoter of the long variant of collagen XVIII, the precursor of endostatin, contains liver-specific regulatory elements. Liétard J; Théret N; Rehn M; Musso O; Dargère D; Pihlajaniemi T; Clément B Hepatology; 2000 Dec; 32(6):1377-85. PubMed ID: 11093745 [TBL] [Abstract][Full Text] [Related]
5. 5-Aminolaevulinate synthase gene promoter contains two cAMP-response element (CRE)-like sites that confer positive and negative responsiveness to CRE-binding protein (CREB). Giono LE; Varone CL; Cánepa ET Biochem J; 2001 Jan; 353(Pt 2):307-16. PubMed ID: 11139395 [TBL] [Abstract][Full Text] [Related]
6. Delineation of the insulin-responsive sequence in the rat cytosolic aspartate aminotransferase gene: binding sites for hepatocyte nuclear factor-3 and nuclear factor I. Beurton F; Bandyopadhyay U; Dieumegard B; Barouki R; Aggerbeck M Biochem J; 1999 Nov; 343 Pt 3(Pt 3):687-95. PubMed ID: 10527950 [TBL] [Abstract][Full Text] [Related]
8. Members of the nuclear factor 1 transcription factor family regulate rat 3alpha-hydroxysteroid/dihydrodiol dehydrogenase (3alpha-HSD/DD AKR1C9) gene expression: a member of the aldo-keto reductase superfamily. Hung CF; Penning TM Mol Endocrinol; 1999 Oct; 13(10):1704-17. PubMed ID: 10517672 [TBL] [Abstract][Full Text] [Related]
9. Hepatic nuclear factor 3 and high mobility group I/Y proteins bind the insulin response element of the insulin-like growth factor-binding protein-1 promoter. Allander SV; Durham SK; Scheimann AO; Wasserman RM; Suwanichkul A; Powell DR Endocrinology; 1997 Oct; 138(10):4291-300. PubMed ID: 9322942 [TBL] [Abstract][Full Text] [Related]
10. Functional characterization of transcription factor binding sites for HNF1-alpha, HNF3-beta (FOXA2), HNF4-alpha, Sp1 and Sp3 in the human prothrombin gene enhancer. Ceelie H; Spaargaren-Van Riel CC; De Jong M; Bertina RM; Vos HL J Thromb Haemost; 2003 Aug; 1(8):1688-98. PubMed ID: 12911579 [TBL] [Abstract][Full Text] [Related]
11. Repression of 5-aminolevulinate synthase gene by the potent tumor promoter, TPA, involves multiple signal transduction pathways. Guberman AS; Scassa ME; Cánepa ET Arch Biochem Biophys; 2005 Apr; 436(2):285-96. PubMed ID: 15797241 [TBL] [Abstract][Full Text] [Related]
12. SF-1 (steroidogenic factor-1), C/EBPbeta (CCAAT/enhancer binding protein), and ubiquitous transcription factors NF1 (nuclear factor 1) and Sp1 (selective promoter factor 1) are required for regulation of the mouse aldose reductase-like gene (AKR1B7) expression in adrenocortical cells. Aigueperse C; Val P; Pacot C; Darne C; Lalli E; Sassone-Corsi P; Veyssiere G; Jean C; Martinez A Mol Endocrinol; 2001 Jan; 15(1):93-111. PubMed ID: 11145742 [TBL] [Abstract][Full Text] [Related]
13. Regulation of transcription from the hepatitis B virus large surface antigen promoter by hepatocyte nuclear factor 3. Raney AK; Zhang P; McLachlan A J Virol; 1995 Jun; 69(6):3265-72. PubMed ID: 7745673 [TBL] [Abstract][Full Text] [Related]
14. HNF1 and/or HNF3 may contribute to the tissue specific expression of glucokinase gene. Cha JY; Kim HI; Im SS; Li TZ; Ahn YH Exp Mol Med; 2001 Jun; 33(2):59-63. PubMed ID: 11460882 [TBL] [Abstract][Full Text] [Related]
15. E1A represses apolipoprotein AI enhancer activity in liver cells through a pRb- and CBP-independent pathway. Kilbourne EJ; Evans MJ; Karathanasis SK Nucleic Acids Res; 1998 Apr; 26(7):1761-8. PubMed ID: 9512550 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory cross-talk between STAT5b and liver nuclear factor HNF3beta: impact on the regulation of growth hormone pulse-stimulated, male-specific liver cytochrome P-450 gene expression. Park SH; Waxman DJ J Biol Chem; 2001 Nov; 276(46):43031-9. PubMed ID: 11562369 [TBL] [Abstract][Full Text] [Related]
18. Phosphatidylinositol 3-kinase and Ras/mitogen-activated protein kinase signaling pathways are required for the regulation of 5-aminolevulinate synthase gene expression by insulin. Scassa ME; Guberman AS; Varone CL; Cánepa ET Exp Cell Res; 2001 Dec; 271(2):201-13. PubMed ID: 11716532 [TBL] [Abstract][Full Text] [Related]
19. A functional hepatocyte nuclear factor 3 binding site is a critical component of the duck hepatitis B virus major surface antigen promoter. Welsheimer T; Newbold JE J Virol; 1996 Dec; 70(12):8813-20. PubMed ID: 8971010 [TBL] [Abstract][Full Text] [Related]
20. Members of the nuclear factor 1 family and hepatocyte nuclear factor 4 bind to overlapping sequences of the L-II element on the rat pyruvate kinase L gene promoter and regulate its expression. Yamada K; Tanaka T; Noguchi T Biochem J; 1997 Jun; 324 ( Pt 3)(Pt 3):917-25. PubMed ID: 9210417 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]